Annette Reichardt
Annette Reichardt publishes mostly in Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastrointestinal Tumor Research and Treatment, Gastrointestinal disorders and treatments and Gastric Cancer Management and Outcomes.
- World rank
- #951,044 of 7,710,434 ranked researchers
- Rank in Germany
- #46,836 of 364,343
- Works
- 67
- Citations
- 1.1k
- Citations per work
- 16.8
What does Annette Reichardt research?
Annette Reichardt's work is mostly in Medicine (78%), Social Sciences (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5378.5%
- Medicine5378.5%
- Everything else1116.4%
- Social Sciences35.1%
- Social Sciences35.1%
- 1Gastroenterology33% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Surgery13% of their works
- 4Infectious Diseases8% of their works
- 5Health5% of their works
- 6Hematology4% of their works
Research topics
- Gastrointestinal Tumor Research and Treatment
- Gastrointestinal disorders and treatments
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
- Gastrointestinal Bleeding Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Vaccine Coverage and Hesitancy
- Chronic Myeloid Leukemia Treatments
Which keywords describe Annette Reichardt's research?
The keywords of their largest research topics: Prognostic Factors, Imatinib Mesylate, Sunitinib, Chemotherapy, Clinical Practice Guidelines, Intussusception, Meckel's Diverticulum and Endoscopic Resection.
- Imatinib
- Vaccine Hesitancy
- Coronavirus
- Upper Gastrointestinal Bleeding
- Soft Tissue Sarcoma
- Mutation
- Endoscopic Resection
- Intussusception
- Chemotherapy
- Imatinib Mesylate
- Prognostic Factors
- Sunitinib
- Clinical Practice Guidelines
- Meckel's Diverticulum
- Gastric Cancer
- Osteosarcoma
- Capsule Endoscopy
- COVID-19 Vaccine
- SARS-CoV-2
- BCR-ABL
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors272 topics
- Imatinib Mesylate211 topic
- Sunitinib211 topic
- Chemotherapy142 topics
- Clinical Practice Guidelines142 topics
- Intussusception91 topic
- Meckel's Diverticulum91 topic
- Endoscopic Resection81 topic
- Gastric Cancer81 topic
- Mutation72 topics
- Osteosarcoma61 topic
- Soft Tissue Sarcoma61 topic
- Capsule Endoscopy51 topic
- Upper Gastrointestinal Bleeding51 topic
- COVID-19 Vaccine41 topic
- Coronavirus41 topic
- SARS-CoV-241 topic
- Vaccine Hesitancy41 topic
- BCR-ABL31 topic
- Imatinib31 topic
Where does Annette Reichardt work?
Annette Reichardt's main affiliation in the publication record is Helios Hospital Berlin-Buch, Germany.
How many publications and citations does Annette Reichardt have?
OpenAlex counts 67 works and 1,125 citations for Annette Reichardt, an h-index of 12, ranking #951,044 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Annette Reichardt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.